cisplatin,gemcitabine,nivolumab
bms
['congrat', 'mibc', 'cisplatin', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo', 'gemcitabine', 'bladder']
congrats gc+nivo with high ccr rates and improved bladder intact mfs. with our novel therapies, do we need tmt with rt for selective bladder preservation?
#gu23 
Director of GU Medical Oncology @RushMedical Assistant Professor. GU Executive Officer - Alliance for Clinical Trials in Oncology